Unpublished Newswire
More than two years after paying out $4.99 million in an allegedly bogus refund, the Canada Revenue Agency is stuck in Federal Court trying to figure out where the money went and how to get it back.
October 27, 2025 - 04:00 | | CBC News - Ottawa
A developer that had been facing the potential of more than $30 million in fines from Ontario’s Home Construction Regulatory Authority has had all counts against it dropped. Briarwood Development Group was accused of coercing buyers into paying more for homes they'd already signed agreements for.
October 27, 2025 - 04:00 | | CBC News - Ottawa
When Drake was a teenager, he'd stand outside Toronto's long-gone Escape Nightclub handing out flyers just to get inside and lose himself in Vybz Kartel's music. On Sunday night, he came full circle, recalling that memory on stage as he welcomed the dancehall star for his first-ever Canadian concert at Scotiabank Arena.
October 27, 2025 - 03:23 | Globalnews Digital | Global News - Ottawa
Doctors are calling on provinces to bolster addiction treatment services in response to growing opioid use among young people, a crisis they fear will escalate for decades to come if immediate action is not taken.In a Canadian Medical Association Journal (CMAJ) editorial published Monday, physicians Shannon Charlebois and Shawn Kelly say the escalation of opioid use among youth is being overlooked. Existing addiction services, they say, are also inadequate to meet the needs of young people with opioid use disorder, or OUD.
October 27, 2025 - 00:01 | Alanna Smith | The Globe and Mail
The Alberta government is expected to introduce back-to-work legislation on Monday to force striking teachers to return to classrooms after three weeks, raising fears among labour advocates that the province will invoke the Charter’s notwithstanding clause to override workers’ rights. More than 750,000 students have been out of class since Oct. 6, after negotiations between the Alberta Teachers’ Association and the province broke down.
October 26, 2025 - 21:24 | Meera Raman | The Globe and Mail
Health Canada has for the first time approved a disease-modifying drug for Alzheimer’s disease, a watershed moment that offers hope for patients but does not guarantee that the complex and expensive intravenous therapy will be widely available in this country. The federal regulator on Friday granted a conditional authorization for lecanemab, an antibody drug that can slow the progression of the disease for some people with mild cognitive impairment or early-stage dementia owing to Alzheimer’s.
October 26, 2025 - 21:08 | Kelly Grant | The Globe and Mail
